Adjuvant FOLFOX Improved DFS in yp Stage III Rectal Cancer

Leah LawrenceJun 6, 2018In the ADORE trial, adjuvant FOLFOX in postoperative yp stage III rectal cancer significantly improved disease-free survival.

Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news